Condition
Hip Impingement Syndrome
Total Trials
5
Recruiting
0
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Completed2
Withdrawn1
Terminated1
Active Not Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05720806Not ApplicableActive Not RecruitingPrimary
Weight Bearing Status Post-hip Arthroscopy
NCT05893823CompletedPrimary
Retrospective Study on Radiological Factors Predictive of Psoas Impingement
NCT04212650Phase 1Terminated
Losartan to Improve Hip Microfracture
NCT05310240Completed
Analysis of the Relevance of Radiologic Parameters on the Outcome After Hip Arthroscopy
NCT05710146Phase 3Withdrawn
Tranexamic Acid (TXA) in Hip Arthroscopy
Showing all 5 trials